Clinical Trial Update: Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

View source ↗

Summary

Pediatric natural history study investigating MYBPC3 mutation-associated cardiomyopathy, currently recruiting to characterize disease course.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Tenaya Therapeutics | Conditions: Cardiomyopathy | Status: RECRUITING